Mindpeak Featured in Ada Ventures’ Bio‑Infrastructure Spotlight

July 24, 2025

We’re excited to share that Mindpeak has been recognized by Ada Ventures as part of a select group of innovators building the next-generation infrastructure for global health.

In their recent spotlight, Ada Ventures highlights the urgency of rethinking healthcare systems to meet the demands of a longer-living, more complex global population. Their vision spans five critical pillars of bio‑infrastructure—from lab automation to talent development, with Mindpeak featured under "Patient Data Platforms" for our contributions to secure, inclusive, and actionable health data.

At Mindpeak, we’re proud to play a pivotal role in this transformation:

Advancing Precision Diagnostics

Our AI software brings cutting-edge biomarker translation directly into pathology workflows—supporting clinicians in identifying breast, lung, and other cancers with speed and precision.

Making Patient Data Clinically Useful

Unlike conventional data platforms, we focus on real-time, tissue-based insights that are immediately actionable in the clinic. This enables faster decision-making and more equitable access to personalized care.

Scaling Globally

With deployments across 20+ countries and partnerships with leading labs, we’re not just imagining the future, we’re delivering it, one slide at a time.

We’re honored to be included alongside visionary companies across the healthcare and life sciences ecosystem. Together, we’re helping build a world where AI, data, and infrastructure truly serve everyone.

🔗 Read Ada Ventures’ full bio‑infrastructure spotlight

In the News

Related reading

We’re proud to see our VP Precision Medicine, Patrick Frey, featured in Oncology Times sharing his perspective on one of oncology’s most urgent challenges – achieving true equity in biomarker testing.
In the News
8 min read

Mindpeak in Oncology Times

We’re proud to see our VP Precision Medicine, Patrick Frey, featured in Oncology Times sharing his perspective on one of oncology’s most urgent challenges – achieving true equity in biomarker testing.

We’re proud to see our VP Precision Medicine, Patrick Frey, featured in Oncology Times sharing his perspective on one of oncology’s most urgent challenges – achieving true equity in biomarker testing.

As Patrick notes, the conversation must move from if to how. The science and technology already exist; now it’s about ensuring every patient, everywhere, can access and benefit from them.

At Mindpeak, we believe AI-powered pathology can help close that gap – supporting faster, more consistent insights that make precision medicine truly accessible.

In the News
8 min read

AI-Enabled Pathology: De-risking Oncology Drug Development

We are delighted to share that Aurélie Fugon, VP Predictive AI Solutions at Mindpeak, is featured in Life Science Daily News.

In her article, Aurélie outlines how AI-supported biomarker-driven strategies can reduce variability in pathology, improve the consistency of patient selection and help de-risk late-stage trials.

All key enablers of more reliable, data-rich clinical decision-making. With Aurélie’s leadership, we’re strengthening collaborations with pharma, biotech and clinical partners to help bring reproducible, scalable biomarker assessment into real-world research settings, shaping the future of predictive AI in precision oncology.

Read the full article here: https://lifesciencedaily.news/ai-enabled-pathology-de-risking-oncology-drug-development/

In the News
8 min read

United by Unique: Advancing Personalised Cancer Care on World Cancer Day

Every person with cancer is unique. So is every diagnosis - and every pathology sample that informs it.

This year’s World Cancer Day theme continues the focus on United by Unique, highlighting the importance of early detection, equitable access, and truly personalised care. It is a powerful reminder that behind every case is an individual with distinct biology, circumstances, and needs.

At Mindpeak, we believe precision medicine should be a right, not a privilege. Scientific and technological advances have transformed what is possible in cancer diagnostics. The challenge now is ensuring these innovations reach patients in ways that reflect their individuality.

Advanced AI models in digital pathology can help bridge this gap. By accelerating insights from complex tissue data and supporting clinicians with consistent, high-quality analysis, AI contributes to faster, more precise and more personalised decision-making.

On World Cancer Day, we stand with the global community in raising awareness and championing approaches that put people first. When we see the person before the disease, we move closer to a future where every individual’s uniqueness is recognized - and reflected - in their care.

Ready to advance your diagnostics

Connect with our team to explore how precision pathology works in your setting